Almost daily there are new recommendations for how to treat prostate cancer and an equal number of controversies surrounding the recommendations. What is a man to do when faced with the words, “you have prostate cancer”?
The good news is that there are many proven options to consider; but how do you choose the best one for you? The decision can be daunting and the controversies swirling in the news only increase the confusion when wading through the information. You may be considering:
Active surveillance (watchful waiting) is an option for those who want to closely monitor their cancer over short intervals. Intervention is considered if the cancer grows quickly, PSA scores increase or other ...
National Principal Investigator, CyberKnife Radiosurgery for Organ-Confined Prostate
Cancer: Homogenous Dose Distribution. An on-going multi-institutional study; ClinicalTrials.gov Identifier: NCT00643994
Meier R, Beckman A et al. Stereotactic Radiotherapy for Organ-confined Prostate Cancer:
First AuthorEarly Toxicity and Quality of Life Outcomes from a Multi-institutional Trial. Intern J Radiat Oncol Biol Phys 78(3): S57, 2010
Meier R, Sanda M, Kaplan I. Robotic Radiosurgery for Organ-confined Prostate Cancer: Early Toxicity Outcomes from a Multi-institutional Trial. J Urology 183(4): e785, 2010
Meier R, Cotrutz C. MRI-planned Stereotactic Body Radiotherapy for Organ-confined Prostate Cancer: Feasibility & Early Results. Intern J Radiat Oncol Biol Phys 75(3):S334, 2009
Meier R, Mehta V, Vermeulen S, Young R. Dose-response and dose-complication
relationships in stereotactic radiosurgery for trigeminal neuralgia. Intern J Radiat Oncol Biol Phys. 60(1): S547, 2004
Meier R, Hatton J, Mehta V. Forward-planning breast IMRT: early clinical experience. Intern J Radiat Oncol Biol Phys. 57(2): S368, 2003
Meier R, Brawer M. Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapy. Reviews in Urology. 4(3); 141-46, 2002
Meier R, Mark R, St. Royal L, Tran L, Colburn G, Parker R. Postoperative radiotherapy
following radical prostatectomy for prostate carcinoma. Cancer. 1992; 70:1960-1966.
Posnsky L, Fuller D, Meier R, Ma C (Editors): Treating Prostate Cancer and Related Genitourinary Applications. New York: Springer-Verlag, 2012.
Vermeulen S, Cotrutz C, Morris A, Meier R, Buchanan C, Dawson P, Porter B. Accelerated partial breast irradiation: using the CyberKnife as the radiation delivery platform in the treatment of early breast cancer. Front. Oncol. 1:43, 2001.
Young RF, Li F, Vermeulen S, Meier R, Gamma Knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg. 2009 Nov 6.
Sylvester J, Blasko J, Grimm P, Meier R, Malmgren J. Ten-year biochemical relapse-free
survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Intern J Radiat Oncol Biol Phys. 57(4): 944-52, 2003
Grimm P, Blasko J, Sylvester J, Meier R, Cavanagh W. Ten-year biochemical (prostate- specific antigen) control of prostate cancer with 125-I brachytherapy. Intern J Radiat Oncol
Biol Phys. 51(1): 31-40, 2001
Sylvester J, Grimm P, Blasko J, Meier R, Spiegel J, Heaney C, Cavanagh W. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns or urologists and radiation oncologists in the United States. Urology. 58(2 suppl 1):65-70, 2001.
Grimm P, Blasko J, Sylvester J, Cavanagh W, Meier R. Ten year biochemical outcomes following 125-iodine monotherapy for early stage prostate cancer. Intern J Radiat Oncol Biol Phys. 48(3): 146-147, 2000.
Sylvester J, Blasko J, Grimm P, Meier R, Cavanagh W. Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate brachytherapy in early-stage prostate cancer: a matched subset analysis. Molecular Urology. 4(3):155-59, 2000
Vermeulen S, Young R, Li F, Meier R, Raisis J, Klein S, Kohler E. Comparison of single fraction radiosurgery tumor control and toxicity in the treatment of basal and nonbasal meningiomas. Stereotact & Funct Neurosurg. 72(suppl. 1): 60-66, 1999.
Sylvester J, Blasko J, Grimm P, Meier R, Colburn G, Goy B, Cavanagh W. Neoadjuvant
androgen ablation combined with exernal beam radiotherapy and brachytherapy in early
stage prostate cancer. Molecular Urology. 1999; 3:231-238.
Tran L, Mark R, Meier R, Calcaterra T, Parker R. Sarcomas of the head and neck:
Prognostic factors and treatment strategies. Cancer. 1992; 70:169-177.
Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of
National MeetingsLife Outcomes from a Multi-institutional Trial. 52nd Annual Meeting of the American Society for Therapeutic Radiation Oncology, November 2010, San Diego, California
Radiosurgery for Organ-confined Prostate Cancer: Early Toxicity Outcomes from a Multi-institutional Trial. 105th Annual Meeting of the American Urologic Association, June 2, 2010, San Francisco, California
MRI-Planned Stereotactic Body Radiotherapy for Organ-Confined Prostate Cancer: Feasibility
and Early Results. 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology, November 2009, Chicago, Illinois
Stereotactic body radiotherapy for organ-confined prostate cancer: Feasibility and early results. Presented at the 91st Annual Meeting of the American Radium Society, April 2009.
Dose-response and dose-complication relationships in stereotactic radiosurgery for trigeminal
neuralgia. Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiation Oncology, October, 2004, Atlanta, Georgia
Forward-planning breast IMRT: early clinical experience. Presented at 45th Annual Meeting of the American Society for Therapeutic Radiation Oncology, October 2003, Salt Lake City Utah
Acute genitourinary complications of permanent interstitial prostate brachytherapy,
National Meetingspresented at the Annual Meeting of the Radiologic Society of North America, November 1999.
Postoperative radiation therapy for pathologic stage C prostate carcinoma, presented at the
71st Annual Meeting of the American Radium Society, April 1989.
CyberKnife Radiotherapy, Swedish Radiosurgery Center (Swedish Hospital)
Stereotactic radiosurgery using the Gamma Knife, for intracranial neoplasias and functional
Disorders, Swedish Radiosurgery Center (Swedish Hospital)
Permanent transperineal prostate brachytherapy (Seattle Prostate Institute, Swedish Cancer Institute, and Southwest Tumor Institute)
Temporary transperineal prostate brachytherapy (HDR, Swedish Hospital; LDR training at
California Endocurietherapy and Long Beach Memorial Medical Center)
Interstitial and intracavitary brachytherapy for gynecologic and head and neck malignancies, Stanford Hospital and Kaiser Santa Clara Hospital
Intravascular coronary brachytherapy to prevent restenosis (Swedish Hospital)
Intraoperative radiotherapy (orthovoltage unit, Stanford University Hospital)
Externally applied hyperthermia (Palo Alto Medical Foundation)